Biogen Inc. (BIIB)

Last Closing Price: 155.51 (2025-11-07)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Biogen Inc. (BIIB) had Net Income of $466.50M for the most recently reported fiscal quarter, ending 2025-09-30.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
$2.53B
Net Income
$466.50M
$674.40M
$1.86B
$1.94B
$591.40M
$-34.10M
$557.30M
$557.30M
$466.50M
$466.50M
$466.50M
$466.50M
$591.40M
$855.10M
146.60M
147.10M
$3.18
$3.17
Balance Sheet Financials
$8.94B
$3.08B
$20.27B
$29.21B
$3.29B
$6.29B
$7.71B
$11.00B
$18.21B
$2.38B
$18.21B
146.70M
Cash Flow Statement Financials
$1.69B
$-139.40M
$-164.90M
$2.38B
$3.86B
$1.49B
$231.20M
--
--
Fundamental Metrics & Ratios
2.72
--
--
0.26
0.35
73.39%
23.33%
23.33%
--
21.99%
18.40%
$1.58B
--
--
--
0.09
0.31
1.84
48.79
2.56%
19.56%
1.60%
1.90%
$124.11
$10.76
$11.51